All Search Results
News Releases
Sep 29, 2026, 11:26 ET Velo Palmetto Joins Team In Training as Blood Cancer United Advances Goal of Giving Patients More Time
patients, families and caregivers.About Blood Cancer United®Blood Cancer United® (formerly The Leukemia & Lymphoma Society) is the largest global nonprofit focused on blood cancer patient support, research, and advocacy. Since their founding in 1949, the organization
More news about: BLOOD CANCER UNITED, INC.
Sep 29, 2026, 08:30 ET HUYABIO International Announces Pivotal Data for HBI-8000 in Advanced Melanoma Selected for Late-Breaking Presentation at ESMO Congress 2026
as monotherapy for the treatment of T-cell lymphoma in China (as Epidaza ®) and Japan (as HIYASTA®), and in combination with an aromatase inhibitor for breast cancer in China and Taiwan, and in combination with R-CHOP in diffuse large B-cell lymphoma in China.About the Phase 3 HBI-8000-303
More news about: HUYABIO International
Sep 28, 2026, 09:00 ET Kaluz Restaurant and Max's Grille Unite to Fight Blood Cancer
maxsgrille.com.About Blood Cancer UnitedBlood Cancer United® (formerly The Leukemia & Lymphoma Society) is the largest global nonprofit focused on blood cancer patient support, research, and advocacy. Since their founding in 1949, the organization
More news about: Arka Restaurant Group
Sep 28, 2026, 06:30 ET Jaypirca® (pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) Across All Lines of Therapy
mainland China by Innovent Biologics.About Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)CLL/SLL is a form of slow-growing non-Hodgkin lymphoma that develops from white blood cells known as lymphocytes[6],[7]. CLL/SLL is one
More news about: Innovent Biologics
Sep 25, 2026, 17:11 ET FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata
immune system problems. Olumiant may increase your risk of lymphoma and other cancers, including skin cancers. People taking a medicine in the class of medicines called JAK inhibitors have a higher risk of certain cancers, including lymphoma and lung cancer, especially if you are a current or past smoker.
More news about: Eli Lilly and Company
